# AEL03 listing is produced correctly

    Code
      result
    Output
      Listing of Serious Adverse Events
      
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
                                                                                                Date of                                                                                    Reason  
                                                                               Adverse        First Study     Study       AE        Most      Caused by                         Action   Classified
                                                                             Event MedDRA         Drug        Day of   Duration    Extreme      Study     Outcome   Treatment   Taken    as Serious
      Center/Patient ID            Age/Sex/Race              Treatment      Preferred Term   Administration   Onset    in Days    Intensity     Drug        (1)      for AE      (2)        (3)    
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      BRA-1/id-134        47/M/WHITE                       A: Drug X        dcd A.1.1.1.2      04NOV2020       322       149      MODERATE       No          5         Yes        2          4     
                                                                            dcd A.1.1.1.2      04NOV2020       394        43      MODERATE       No          5         No         5          5     
      BRA-1/id-141        35/F/WHITE                       C: Combination   dcd A.1.1.1.2      25JUL2020       900       139      MODERATE       No          4         Yes        2          4     
                                                                            dcd D.1.1.1.1      25JUL2020       1094       3        SEVERE        Yes         1         No         6          1     
      BRA-1/id-236        32/M/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd B.1.1.1.1      15JAN2021        33       615       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.1.1.1.1      15JAN2021       271       776       SEVERE        Yes         1         Yes        6          1     
                                                                            dcd B.1.1.1.1      15JAN2021       1052       7        SEVERE        Yes         1         Yes        6          1     
      BRA-1/id-265        25/M/WHITE                       C: Combination   dcd D.1.1.1.1      07OCT2019       686        37       SEVERE        Yes         1         No         6          1     
      BRA-1/id-42         36/M/BLACK OR AFRICAN AMERICAN   A: Drug X        dcd D.1.1.1.1      01JAN2020        65       630       SEVERE        Yes         1         No         6          1     
                                                                            dcd A.1.1.1.2      01JAN2020       160       260      MODERATE       No          2         Yes        2          4     
                                                                            dcd B.2.2.3.1      01JAN2020       292        51        MILD         No          3         No         2          4     
                                                                            dcd A.1.1.1.2      01JAN2020       460       195      MODERATE       No          5         Yes        2          5     
                                                                            dcd B.1.1.1.1      01JAN2020       470       131       SEVERE        Yes         1         No         6          1     
                                                                            dcd A.1.1.1.2      01JAN2020       476       113      MODERATE       No          4         Yes        2          4     
                                                                            dcd B.1.1.1.1      01JAN2020       642        15       SEVERE        Yes         1         Yes        6          1     
      BRA-1/id-65         25/F/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd B.1.1.1.1      15JUL2019       349       442       SEVERE        Yes         1         No         6          1     
      BRA-1/id-93         34/F/ASIAN                       A: Drug X        dcd D.1.1.1.1      20JUN2020       317       250       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.1.1.1.1      20JUN2020       524        24       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.2.2.3.1      20JUN2020       597        10        MILD         No          3         Yes        2          4     
      BRA-11/id-321       33/F/ASIAN                       C: Combination   dcd A.1.1.1.2      06OCT2020       428       335      MODERATE       No          3         No         2          2     
                                                                            dcd B.1.1.1.1      06OCT2020       893        58       SEVERE        Yes         1         Yes        6          1     
      BRA-11/id-345       37/F/WHITE                       A: Drug X        dcd B.1.1.1.1      18AUG2020       1010       35       SEVERE        Yes         1         No         6          1     
      BRA-11/id-397       38/M/ASIAN                       A: Drug X        dcd D.1.1.1.1      27JUN2020       517       441       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.1.1.1.1      27JUN2020       1012       30       SEVERE        Yes         1         Yes        6          1     
      BRA-11/id-50        26/M/BLACK OR AFRICAN AMERICAN   A: Drug X        dcd A.1.1.1.2      28APR2019       1008       68      MODERATE       No          3         Yes        2          5     
      BRA-11/id-9         40/M/ASIAN                       C: Combination   dcd B.2.2.3.1      25MAR2019       441        53        MILD         No          5         No         2          3     
                                                                            dcd D.1.1.1.1      25MAR2019       445       598       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.1.1.1.1      25MAR2019       644        42       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.2.2.3.1      25MAR2019       669       100        MILD         No          5         Yes        2          3     
      BRA-12/id-59        36/M/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd D.1.1.1.1      25NOV2019        9        233       SEVERE        Yes         1         Yes        6          1     
                                                                            dcd B.2.2.3.1      25NOV2019       230       160        MILD         No          3         No         2          3     
      BRA-13/id-177       24/M/WHITE                       A: Drug X        dcd B.1.1.1.1      30AUG2020       249       470       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.1.1.1.1      30AUG2020       1013       33       SEVERE        Yes         1         No         6          1     
      BRA-14/id-120       33/F/ASIAN                       C: Combination   dcd A.1.1.1.2      19SEP2020        4        246      MODERATE       No          2         No         5          6     
                                                                            dcd A.1.1.1.2      19SEP2020        75       393      MODERATE       No          6         No         2          6     
                                                                            dcd A.1.1.1.2      19SEP2020        93       329      MODERATE       No          6         No         2          3     
                                                                            dcd A.1.1.1.2      19SEP2020       208       190      MODERATE       No          5         No         3          4     
                                                                            dcd A.1.1.1.2      19SEP2020       251       143      MODERATE       No          3         No         5          4     
                                                                            dcd B.2.2.3.1      19SEP2020       505        7         MILD         No          4         No         7          6     
      BRA-15/id-36        38/F/ASIAN                       A: Drug X        dcd B.1.1.1.1      08JAN2020       372       154       SEVERE        Yes         1         Yes        6          1     
                                                                            dcd A.1.1.1.2      08JAN2020       574       134      MODERATE       No          3         Yes        2          3     
      BRA-2/id-101        34/M/ASIAN                       B: Placebo       dcd A.1.1.1.2      26JUN2020       650       301      MODERATE       No          5         Yes        2          4     
      BRA-2/id-296        44/F/ASIAN                       A: Drug X        dcd A.1.1.1.2      22JAN2021       204       488      MODERATE       No          5         Yes        2          4     
                                                                            dcd A.1.1.1.2      22JAN2021       289       259      MODERATE       No          2         Yes        2          3     
                                                                            dcd B.1.1.1.1      22JAN2021       1043       53       SEVERE        Yes         1         No         6          1     
      BRA-3/id-8          25/F/BLACK OR AFRICAN AMERICAN   B: Placebo       dcd A.1.1.1.2      12MAR2020        48        98      MODERATE       No          3         Yes        3          4     
      BRA-4/id-368        46/M/BLACK OR AFRICAN AMERICAN   C: Combination   dcd D.1.1.1.1      25FEB2020       837       114       SEVERE        Yes         1         No         6          1     
                                                                            dcd B.1.1.1.1      25FEB2020       842       247       SEVERE        Yes         1         No         6          1     
      BRA-4/id-383        30/F/ASIAN                       B: Placebo       dcd A.1.1.1.2      18JAN2020       253       212      MODERATE       No          2         No         6          5     
                                                                            dcd A.1.1.1.2      18JAN2020       286       191      MODERATE       No          4         Yes        7          3     
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      
      (1) Outcome: 1 = fatal; 2 = not recovered/not resolved; 3 = recovered/resolved;
          4 = recovered/resolved with sequelae; 5 = recovering/resolving; 6 = unknown.
      (2) Action taken with study drug: 1 = dose increased; 2 = dose not changed; 3 = dose reduced; 4 = drug interrupted;
          5 = drug withdrawn; 6 = not applicable; 7 = unknown.
      (3) Reason classified as serious: 1 = resulted in death; 2 = life threatening; 3 = required prolonged in patient
          hospitalization; 4 = disabling; 5 = a congenital anomaly/birth defect in offspring of study subject;
          6 = does not meet any of the above serious criteria, but may jeopardize the subject, and may require medical or
          surgical intervention to prevent one of the outcomes listed above.
      *  Study day derived from imputed onset date.
      ** Duration derived from imputed onset date and/or end date.

